Beck Mack & Oliver’s Idexx Laboratories IDXX Stock Holding History

Beck Mack & Oliver’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Sell	575 -125	-18%	-$70.1K	0.01%	170
2026 Q1	$393K	Sell	700 -180	-20%	-$115K	0.01%	148
2025 Q4	$595K	Buy	880 +230	+35%	+$157K	0.01%	128
2025 Q3	$415K	Hold	650	–	–	0.01%	140
2025 Q2	$349K	Sell	650 -550	-46%	-$263K	0.01%	146
2025 Q1	$504K	Sell	1,200 -892	-43%	-$387K	0.01%	131
2024 Q4	$865K	Buy	2,092 +77	+4%	+$33.8K	0.02%	115
2024 Q3	$1.02M	Sell	2,015 -25	-1%	-$12.1K	0.02%	107
2024 Q2	$994K	Sell	2,040 -335	-14%	-$168K	0.02%	108
2024 Q1	$1.28M	Buy	2,375 +250	+12%	+$137K	0.03%	102
2023 Q4	$1.18M	Hold	2,125	–	–	0.03%	100
2023 Q3	$929K	Buy	2,125 +375	+21%	+$187K	0.02%	106
2023 Q2	$879K	Sell	1,750 -100	-5%	-$47.9K	0.02%	110
2023 Q1	$925K	Sell	1,850 -75	-4%	-$35.9K	0.03%	105
2022 Q4	$785K	Hold	1,925	–	–	0.02%	115
2022 Q3	$627K	Hold	1,925	–	–	0.02%	121
2022 Q2	$675K	Sell	1,925 -200	-9%	-$81.6K	0.02%	123
2022 Q1	$1.16M	Sell	2,125 -25	-1%	-$13.2K	0.03%	110
2021 Q4	$1.42M	Sell	2,150 -200	-9%	-$126K	0.03%	103
2021 Q3	$1.46M	Hold	2,350	–	–	0.04%	100
2021 Q2	$1.48M	Hold	2,350	–	–	0.04%	96
2021 Q1	$1.15M	Hold	2,350	–	–	0.04%	104
2020 Q4	$1.18M	Hold	2,350	–	–	0.04%	103
2020 Q3	$924K	Hold	2,350	–	–	0.03%	107
2020 Q2	$776K	Sell	2,350 -50	-2%	-$14.5K	0.03%	114
2020 Q1	$581K	Hold	2,400	–	–	0.03%	130
2019 Q4	$627K	Sell	2,400 -50	-2%	-$13.2K	0.02%	140
2019 Q3	$666K	Hold	2,450	–	–	0.02%	130
2019 Q2	$675K	Hold	2,450	–	–	0.02%	136
2019 Q1	$548K	Sell	2,450 -1,280	-34%	-$264K	0.02%	152
2018 Q4	$694K	Sell	3,730 -200	-5%	-$41K	0.03%	134
2018 Q3	$981K	Sell	3,930 -420	-10%	-$102K	0.03%	123
2018 Q2	$948K	Sell	4,350 -200	-4%	-$41.2K	0.03%	124
2018 Q1	$871K	Sell	4,550 -300	-6%	-$55.4K	0.03%	126
2017 Q4	$758K	Sell	4,850 -200	-4%	-$31.5K	0.02%	132
2017 Q3	$785K	Sell	5,050 -450	-8%	-$71.1K	0.03%	134
2017 Q2	$888K	Sell	5,500 -150	-3%	-$24.4K	0.03%	122
2017 Q1	$874K	Sell	5,650 -50	-0.9%	-$6.89K	0.03%	120
2016 Q4	$668K	Hold	5,700	–	–	0.02%	137
2016 Q3	$643K	Hold	5,700	–	–	0.02%	147
2016 Q2	$529K	Sell	5,700 -150	-3%	-$12.9K	0.02%	186
2016 Q1	$458K	Buy	+5,850	New	+$421K	0.02%	194

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Beck Mack & Oliver's IDXX Position: Q2 2026 in Review

Beck Mack & Oliver reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $70.1K and leaving 575 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #170.

Beck Mack & Oliver first reported a position in IDXX in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.48M in Q2 2021. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Beck Mack & Oliver held 575 shares of Idexx Laboratories worth $303K as of Q2 2026.
Beck Mack & Oliver sold 125 Idexx Laboratories shares in Q2 2026, an estimated $70.1K.
Idexx Laboratories made up 0.01% of Beck Mack & Oliver's portfolio in Q2 2026, its #170 holding.
Beck Mack & Oliver first reported a position in Idexx Laboratories in Q1 2016 and has held it in 42 quarters since.
Beck Mack & Oliver's Idexx Laboratories position peaked at $1.48M in Q2 2021.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.